Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs ATMPs for Thin Endometrial Infertility
NCT06503471Phase 1Suspended
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Dec 2026
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human umbilical cord mesenchymal stem cells in infertility (2 arms), sponsored by Sclnow Biotechnology Co., Ltd. Primary endpoint: Pregnancy outcome at 12 months. Planned start Dec 2026; status: suspended.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06503471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06503471.